Russell Frank Company’s Fortress Biotech FBIO Stock Holding History

Russell Frank Company’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-8	Closed	-$1K	–	2875
2013 Q3	$1K	Hold	8	–	–	﹤0.01%	3387
2013 Q2	$1K	Buy	+8	New	+$1.18K	﹤0.01%	3224

Other funds holding FBIO

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Mutual of America Capital Management New York $8.8B AUM 29.06% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

Russell Frank Company's FBIO Position: Q4 2013 in Review

Russell Frank Company sold out of Fortress Biotech (FBIO) in Q4 2013, closing a stake of 8 shares — an estimated $1K sold.

Russell Frank Company first reported a position in FBIO in Q2 2013 and held it in 2 quarters. The position peaked at $1K in Q3 2013. 60 funds tracked by Wall St. Rank hold FBIO as of Q4 2013.

Russell Frank Company reported no remaining Fortress Biotech position as of Q4 2013 after selling out during the quarter.
Russell Frank Company sold 8 Fortress Biotech shares in Q4 2013, an estimated $1K.
Russell Frank Company first reported a position in Fortress Biotech in Q2 2013 and held it in 2 quarters.
Russell Frank Company's Fortress Biotech position peaked at $1K in Q3 2013.
60 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2013.

Based on Russell Frank Company's 13F filing for Q4 2013, filed 14 Feb 2014.